Laboratories at the Guildford site support formulation strategy, analytical development, product characterization, early process development, GMP manufacturing of clinical trial materials, and stability testing. The facility has a proven track record of advancing complex formulations from early feasibility through clinical-stage manufacturing.

MedPharm UK supports development programs from early formulation through clinical trial material (CTM) production, with experience across both small-molecule and biologic drug products.

Facilities

The Guildford site houses specialized laboratories designed to support the unique requirements of liquid and semi-solid product development, including:

Formulation development laboratories for prototype design and optimization

Process development laboratories supporting scalable, GMP-ready processes, including preclinical supply

Formulation characterization suites for rheology, texture, and delivery profiling

Analytical laboratories supporting method development & validation and GLP release for toxicology studies

MHRA-approved GMP facility for clinical manufacturing

On-site quality control laboratories for raw material testing, batch release, and stability monitoring

This integrated infrastructure enables early identification of formulation and process risks while supporting regulatory readiness.

Specialized Capabilities

The Guildford facility provides technical capabilities that support development continuity and efficient progression to the clinic, including:

Formulation strategy aligned with molecular properties and target product profiles

Rapid prototyping and proof-of-concept evaluation

ICH-compliant stability studies

Clinical trial material (CTM) manufacturing and packaging for Phase I–II studies, with Phase III capability for select programs (including orphan indications)

Analytical method development and validation aligned with regulatory expectations

Process development and scale-up support to enable global technology transfer

These capabilities support programs across liquid and semi-solid dosage forms, for both small molecules and biologics.

Quality and Compliance

Quality and regulatory compliance are integral to operations at MedPharm’s Guildford facility. UK activities are conducted in alignment with MHRA and EU GMP requirements, supported by robust quality assurance and quality control systems, including Qualified Person (QP) oversight.

These systems ensure development activities meet global expectations for quality, data integrity, and regulatory compliance throughout the product lifecycle.